AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / BLANK CHECKS
Drugs Made In America Acquisition Corp. Ordinary Shares
XNAS · usd
SIC 6770 · BLANK CHECKS
FIGI AK-838333E0A0
10.88▼ 0.01 (-0.05%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
—
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
10.88
Day's Range
10.87 – 10.88
52-Week Range
10.30 – 10.89
Volume
91.4K
Avg Volume
34.5K
Share Statistics
Shares Outstanding
Employees
—
Exchange
XNAS
Listed
2025-02-25
Share count as of August 14, 2026

Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)
What is Drugs Made In America Acquisition Corp. Ordinary Shares's Market Cap?
Drugs Made In America Acquisition Corp. Ordinary Shares's Market Cap is $264.0M, based on as-reported figures from SEC (XBRL) filings.
What is Drugs Made In America Acquisition Corp. Ordinary Shares's Enterprise Value?
Drugs Made In America Acquisition Corp. Ordinary Shares's Enterprise Value is $503.9M, based on as-reported figures from SEC (XBRL) filings.
What is Drugs Made In America Acquisition Corp. Ordinary Shares's Trailing P/E?
Drugs Made In America Acquisition Corp. Ordinary Shares's Trailing P/E is 44.4×, based on as-reported figures from SEC (XBRL) filings.
What is Drugs Made In America Acquisition Corp. Ordinary Shares's Net Income (TTM)?
Drugs Made In America Acquisition Corp. Ordinary Shares's Net Income (TTM) is $5.9M, based on as-reported figures from SEC (XBRL) filings.
What is Drugs Made In America Acquisition Corp. Ordinary Shares's Diluted EPS (TTM)?
Drugs Made In America Acquisition Corp. Ordinary Shares's Diluted EPS (TTM) is 0.24, based on as-reported figures from SEC (XBRL) filings.
What is Drugs Made In America Acquisition Corp. Ordinary Shares's Net Debt?
Drugs Made In America Acquisition Corp. Ordinary Shares's Net Debt is -$6.1K, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · DMAAAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Sep 30, 2024
Operating Expenses:
General and administrative costs—
Loss from operations—
OTHER INCOME
Interest earned on cash and investments held in Trust Account—
Total other income—
NET INCOME
Basic net income (loss) per redeemable ordinary share————
Diluted net income (loss) per redeemable ordinary share————